Abiopharma

Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status

IDEAYA Biosciences Announces Positive Interim Phase 2 Data for Darovasertib in the Neoadjuvant Setting of Primary Uveal Melanoma

Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

IFF expands LMR Naturals site in Grasse, advancing naturals innovation leadership

Alkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025

IDEAYA Biosciences and Hengrui Pharma Present Positive Phase 1 Data for IDE849 (SHR-4849), a Potential First-in-Class DLL3 TOP1 ADC, in Small Cell Lung Cancer at the IASLC 2025 World Conference on Lung Cancer

Nuvalent Presents Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025

Burning Rock Reports Second Quarter 2025 Financial Results

Alcon - Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025

Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025